title: Should all patients with sepsis receive anticoagulation? Yes.
authors.affiliation: Service de Réanimation Médicale, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 1, Place de L'Hôpital, 67091, Strasbourg cedex, France. ferhat.meziani@chru-strasbourg.fr.|EA 7293, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de médecine, Université de Strasbourg, Strasbourg, France. ferhat.meziani@chru-strasbourg.fr.
authors.forename: Ferhat
authors.initials: F
authors.lastname: Meziani
authors.affiliation: Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Gando
authors.affiliation: Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium.
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Vincent
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D004211:Disseminated Intravascular Coagulation / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D012772:Shock, Septic / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D018180:Thrombomodulin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D018180:Thrombomodulin; D006493:Heparin